Somatostatin (SRIF) is a neuropeptide which acts as a hormone, a neurotransmitter or an autocrine regulator to inhibit secretion and/or proliferation in endocrine, exocrine, neuronal and tumor cells. SRIF has been implicated in numerous physiological processes ranging from growth to memory as well as in several disorders including endocrine cancers and Alzheimer's disease. The biological actions of this peptide are initiated by binding to plasma membrane receptors which are coupled to effector enzymes and ion channels via o proteins. Recently five related SRIF receptor (sstr) genes have been identified by molecular cloning. These sstr subtypes are believed to serve unique biological roles by virtue of their tissue specific expression and particular biochemical properties. However, we do not understand the function of any individual sstr in its normal cellular milieu. Such studies have been difficult because SRIF- responsive tissues and cell lines often express multiple sstr's and, in the absence of subtype specific SRIF analogs, the actions of individual receptors cannot be identified. Moreover, sstr function depends on cellular environment so that the behavior of a receptor expressed in heterologous cells does not necessarily mimic that of endogenous receptors. This proposal has two overall goals: (l) characterize the signal transduction mechanisms activated by sstr subtypes, and (2) elucidate the mechanisms involved in the regulation of sstr's. In the last award period, we developed several receptor antibodies each of which immunoprecipitates the corresponding sstr subtype specifically. Moreover, we developed conditions such that the G-proteins coupled to sstr's in membranes remain receptor associated in the immunoprecipitate. We propose to characterize the G proteins coupled to each sstr subtype in different target cells by immunoprecipitating each receptor and identifying the associated G protein subunits with G protein specific antisera. We will therefore determine how cellular milieu affects the specificity of sstr-G protein coupling. Further, we will use biochemical and electrophysiological techniques to identify the effectors regulated by individual receptor subtypes in different target cells. We also propose to examine the mechanisms involved in sstr desensitization and regulation. Some SRIF responses are rapidly desensitized whereas others are not. Moreover, we have shown that sstr's are subject to chronic regulation by several different hormones. We propose to determine how specific hormonal treatments alter the expression of different sstr subtype mRNAs and proteins. In addition, we will examine the role of receptor phosphorylation in SRIF desensitization. Together these studies will elucidate the cellular mechanisms by which SRIF induces its biological actions and will identify the molecular basis for hormone induced changes in cellular responsiveness to SRIF.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK032234-12
Application #
2138775
Study Section
Biochemical Endocrinology Study Section (BCE)
Program Officer
Abraham, Kristin M
Project Start
1995-07-01
Project End
1999-06-30
Budget Start
1995-07-01
Budget End
1996-06-30
Support Year
12
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of Texas Health Science Center Houston
Department
Pharmacology
Type
Schools of Medicine
DUNS #
City
Houston
State
TX
Country
United States
Zip Code
77225
Schonbrunn, Agnes (2015) Editorial: Reproducibility in Research: A Cautionary Tale and Lessons Not Learned. Mol Endocrinol 29:1219-21
Schonbrunn, Agnes (2014) Editorial: Antibody can get it right: confronting problems of antibody specificity and irreproducibility. Mol Endocrinol 28:1403-7
Waser, Beatrice; Cescato, Renzo; Liu, Qisheng et al. (2012) Phosphorylation of sst2 receptors in neuroendocrine tumors after octreotide treatment of patients. Am J Pathol 180:1942-9
Körner, Meike; Waser, Beatrice; Schonbrunn, Agnes et al. (2012) Somatostatin receptor subtype 2A immunohistochemistry using a new monoclonal antibody selects tumors suitable for in vivo somatostatin receptor targeting. Am J Surg Pathol 36:242-52
Ghosh, Madhumita; Schonbrunn, Agnes (2011) Differential temporal and spatial regulation of somatostatin receptor phosphorylation and dephosphorylation. J Biol Chem 286:13561-73
Kao, Yachu J; Ghosh, Madhumita; Schonbrunn, Agnes (2011) Ligand-dependent mechanisms of sst2A receptor trafficking: role of site-specific phosphorylation and receptor activation in the actions of biased somatostatin agonists. Mol Endocrinol 25:1040-54
Cescato, Renzo; Loesch, Kimberly A; Waser, Beatrice et al. (2010) Agonist-biased signaling at the sst2A receptor: the multi-somatostatin analogs KE108 and SOM230 activate and antagonize distinct signaling pathways. Mol Endocrinol 24:240-9
Liu, Qisheng; Bee, Mark S; Schonbrunn, Agnes (2009) Site specificity of agonist and second messenger-activated kinases for somatostatin receptor subtype 2A (Sst2A) phosphorylation. Mol Pharmacol 76:68-80
Liu, Q; Dewi, D A; Liu, W et al. (2008) Distinct phosphorylation sites in the SST2A somatostatin receptor control internalization, desensitization, and arrestin binding. Mol Pharmacol 73:292-304
Schonbrunn, Agnes (2008) Selective agonism in somatostatin receptor signaling and regulation. Mol Cell Endocrinol 286:35-9

Showing the most recent 10 out of 47 publications